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Summary (248/250) 284 
Background 285 
Pathogens in drain biofilms pose a significant hospital acquired infection risk. Yet, the 286 
evidence of product effectiveness in controlling drain biofilm and pathogen dissemination are 287 
scarce. A novel in vitro biofilm model was developed to address the need for a robust, 288 
reproduceable and simple testing methodology for disinfection efficacy against a complex 289 
drain biofilm. 290 
Methods 291 
Identical complex drain biofilms were simultaneously established over 8 days mimicking a 292 
sink trap. Reproducibility of their composition was confirmed by Next Generation 293 
Sequencing. The efficacy of sodium hypochlorite 1,000 ppm (NaOCl), sodium 294 
dichloroisocyanurate 1,000 ppm (NaDCC), non-ionic surfactant (NIS), and peracetic acid 295 
4,000 ppm (PAA) was explored simulating normal sink usage conditions. Bacterial viability 296 
and recovery following a series of 15 min treatments was measured in three distinct parts of 297 
the drain. 298 
Results 299 
The drain biofilm consisted of 119 mixed species of gram-positive and -negative bacteria. 300 
NaOCl produced a >4 log10 reduction in viability in the drain front section only, while PAA 301 
achieved a >4 log10 reduction in viability in of all the drain sections following 3x15 min doses 302 
and prevented biofilm regrowth for more than 4 days. NIS and NaDCC failed to control the 303 
biofilm in any of the drain sections.  304 
Conclusions 305 
Drains are one source of microbial pathogens in healthcare settings. Microbial biofilms are 306 
notoriously difficult to eradicate with conventional chemical biocidal products. The 307 
development of this reproducible in vitro drain biofilm model enabled understanding of the 308 
impact of biocidal products on biofilm spatial composition and viability in different parts of the 309 
drain. 310 
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Introduction 312 
 313 
The hospital water environment has been recognised as a reservoir of harmful pathogens. 314 
Sinks and faucets can be a transmission source of dangerous bacteria including 315 
carbapenem-resistant Enterobacteriaceae (CRE) [1], multidrug resistant gram-negative 316 
bacilli [2] or extended-spectrum  β-lactamase (ESBL)-producing Enterobacteriaceae [3]. 317 
Splashes from contaminated sink can reach up to 1 m away from the sink [1], posing a close 318 
proximity threat to patients. The main reservoir of pathogens resides in sink traps and U-319 
bends of sinks that are constantly rich in nutrients and constantly hydrated. According to 320 
Kotay et al. [4], it takes only 7 days for Escherichia coli culture to travel from the 321 
contaminated P-trap to the strainer. Increase in hospital outbreaks linked to sinks is raising 322 
concerns [4].  323 
Evidence of product effectiveness in controlling drain biofilms, pathogen dissemination and 324 
biofilm regrowth is overall limited. Interventions to tackle drain associated nosocomial 325 
infections include covering the drains, replacing contaminated reservoirs and enhancing 326 
disinfection procedures (e.g. usage of acetic acid). It is difficult to establish the most effective 327 
intervention, as in most of the clinical cases, a combined approach is taken. Gordon et al. [5] 328 
investigated 66 sink-related infection control interventions to find out that only 9 resulted in 329 
outbreak cessation and bacteria elimination from the drain system. Twenty-two interventions 330 
discontinued the outbreak only. This means that more than a half of all infection control 331 
measures were not effective. Ineffective treatments included those with alcohol, bleach, 332 
chlorine, pressurised steam, hydrogen peroxide, silver nitrate or sodium hydroxide [5,6]. 333 
Controlling bacteria in drains is especially challenging since they attach and grow as a 334 
biofilm, a complex microbial community highly resistant to disinfection [7]. Control of drain 335 
biofilm may thus be difficult to achieve. Efficacy of an intervention is measured as a 336 
decrease in bacterial viability following treatment. Biofilm regrowth and damage to the biofilm 337 
structure is rarely reported [1].  338 
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The aim of this study was to develop a robust, reproducible and reliable in vitro model 339 
imitating drain biofilm formation in a sink trap. Reproducibility of the drain biofilm allowed to 340 
perform standardised disinfectant testing mimicking the use of a product in practice, giving 341 
valuable information about various products bactericidal efficacy against a mixed species 342 
drain biofilm, together with their impact on biofilm structure and biofilm regrowth post-343 
treatment. 344 
 345 
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Methods 347 
 348 
Drain biofilm material  349 
Drain biofilm material was collected from a sink U-bend from a common room at the School 350 
of Pharmacy and Pharmaceutical Sciences, Cardiff University. The room was used by 351 
members of staff for dishwashing, handwashing, meal preparation and beverage 352 
preparation.  353 
To create drain culture suspension, dense drain biofilm material (4.5 g) was diluted in 354 
phosphate buffer saline (PBS, Fisher Bioreagents™, Fisher Scientific, Loughborough, UK) at 355 
1:10 ratio and stored in -20°C freezer in 25% glycerol (Fisher BioReagents™, Fisher 356 
Scientific, Loughborough, UK).   357 
 358 
Drain biofilm formation  359 
Five ml of drain culture suspension (4.5 g of drain biofilm material mixed with 45 ml PBS) 360 
was further diluted in 45 ml 10% tryptone soya broth (TSB; Oxoid, Thermo Fisher Scientific, 361 
Newport, UK). To obtain inoculum of high cell density, the solution was then grown slowly at 362 
ambient temperature (21°C) for 3 days. Following 3 days growth, the high-density inoculum 363 
was placed in a sterile silicon rubber platinum-cured tubing (Outer diameter: ø9mm; inner 364 
diameter: ø6mm; Fisherbrand™, Fisher Scientific, Loughborough, UK). To do so, 10 ml of 365 
high-density inoculum was pipetted into each 41 cm long tube. Inoculum was left inside 366 
tubes for 2 days at 21°C, to allow initial microbial attachment (inoculation phase). 367 
 368 
Drain biofilm growth: trap model 369 
Following inoculation phase, the inoculum was drained out of the tubes. Each tube was cut 370 
into 3 parts (front, middle and back) and fitted into sterile 100 mL Duran™ Clear Glass 371 
Laboratory Bottle (Fisher Scientific, Loughborough, UK) with GL45 screw cap twin hose 372 
connector (Fisher Scientific, Loughborough, UK) that imitated the construction of sink trap 373 
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(Figure S1). Inlet of each front section tube was connected to 10% TSB media via separate 374 
sterile media supply tubing, whereas the outlet of each back section tube was connected to 375 
waste via sterile waste collection tubing. The 10% TSB media was running through tubes via 376 
FH100M multichannel peristaltic pump (Fisher Scientific, Loughborough, UK) at 30 rpm 377 
(equivalent of 30 mL/min) for 10 seconds every 2 hours for a total duration of 6 days (media 378 
supply phase). The arrangement of middle section tube allowed 56 ml of liquid (1:10 TSB 379 
unless otherwise stated) to be trapped inside the bottle. The schematic diagram of the whole 380 
drain biofilm model is shown in Figure S2, with an accent on single tubing line (the maximum 381 
pump capacity was 6 parallel lines). Overall, the complex drain biofilm was formed and 382 
grown for a total duration of 8 days (2 days inoculation phase and 6 days media supply 383 
phase. 384 
 385 
Products tested 386 
Four commercially available products were tested (Table I). Peracetic acid (PAA) and non-387 
ionic surfactant (NIS) are specifically intended for drain cleaning in healthcare settings. All 388 
products were prepared according to manufacturers’ instructions. PAA product came in 389 
granulated form and therefore was applied directly into the tubing; mixing PAA product with 390 
water induced its foaming. Remaining products in liquid form could be introduced directly 391 
through the pump. A 15 minutes contact time was applied for all products to maintain 392 
consistency in methods. Unformulated sodium hypochlorite (NaOCl) 1,000 ppm (ACROS 393 
Organics™, Fisher Scientific, Loughborough, UK) was used as a reference.  394 
 395 
Disinfectant testing: efficacy (log10 reduction) test -3 x 15 min dose 396 
All volumes of product were reduced to reflect the smaller scale of the model. The drain 397 
biofilm model is a 5.3x in vitro scale down of a sink with 32 mm diameter tubing and a 300 398 
mL capacity trap. 399 
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PAA product was introduced into the ø9 mm tubing directly and wetted by 19 mL sterile 400 
water. Nineteen mL (100 mL equivalent for common sink) of NaOCl, NaDCC and NIS 401 
products were introduced with the peristaltic pump at 30 mL/min ensuring the solution 402 
reached the back section of trap model (Figure S1). The solution was left in the tubing for 15 403 
minutes and then neutralised with Dey-Engley broth (DE broth, Neogen® Corporation, Ayr, 404 
UK) for 5 minutes. Neutralisation was performed by introducing the neutraliser with the 405 
peristaltic pump ensuring the solution reached the whole length of the tubing. To reflect the 406 
use of products in practice, a 1 x 15 min dose of disinfectant was applied once per day for 3 407 
days between each treatment (3 x 15 min), the drain biofilm was supplied with sterile water 408 
(instead of 10% TSB) at 30 mL/min for 10 seconds every 2 hours at 21°C. Following the last 409 
15 min dose and neutralisation step, the liquid was drained out from the system and tubing 410 
was disconnected. One cm long pieces of the silicone tubing were cut with sterile scissors 411 
from each section (i.e. front, middle and back) of the trap model.  412 
Each tubing section (1 cm length, ø0.9 cm outer diameter) was sliced open and placed in 413 
sterile McCartney bottle containing 2 mL of DE broth with 100 mg/mL proteinase K (Fisher 414 
Bioreagents™, Fisher Scientific, Loughborough, UK) and 1 g glass beads (Fisher Scientific, 415 
Loughborough, UK), incubated for 1 hour at 37° and then vortexed for 2 minutes. One 416 
hundred µL was serially diluted and 100  µL plated onto tryptone soya agar (TSA; Oxoid, 417 
Thermo Fisher Scientific, Newport, UK) in two technical replicates. Viable count was read 418 
after overnight incubation of the TSA plates at 37°C and log10 reduction was calculated in 419 
relation to untreated drain biofilm samples. 420 
 421 
 422 
Disinfectant testing: 4-days regrowth test 423 
Drain biofilm regrowth was tested 4 days after the 3 x 15 min doses treatment. The tubing 424 
was connected to sterile water between doses and during the regrowth period, with 10s 425 
flushes at 30 rpm every 2 hours at 21°C for up to 4 days. Four days after the last treatment, 426 
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the liquid was drained out from the system and tubing was disconnected. One cm pieces of 427 
tubing were sampled from each section and processed as described above.  428 
 429 
Next generation sequencing (NGS) 430 
The DNA composition of drain biofilm trap model was investigated by Next Generation 431 
Sequencing (NGS). Following the establishment of complex drain biofilm for a total duration 432 
of 8 days, tubing sections (i.e. front, middle and back; Figure S1) were cut and biofilm 433 
recovered as described above. DNA was extracted using Invitrogen™ PureLink™ Genomic 434 
DNA Mini Kit (Fisher Scientific, Loughborough, UK) according to manufacturer’s instructions.  435 
Extracted DNA was quantified using the Quant-iT™ dsDNA Assay Kit, broad range (Fisher 436 
Scientific, Loughborough, UK) according to manufacturer instructions.  437 
Next generation sequencing (NGS) and quality analysis of FASTQ sequence reads was 438 
performed by BaseClear Group, Netherlands. To identify bacterial and archaeal isolates, the 439 
16S rRNA gene (V3-V4) was PCR amplified before sequencing. Illumina MiSeq (PE300) 440 
system was used to generate paired-end sequence reads and blc2fastq2 2.18 software was 441 
utilised to produce FASTQ sequence files. Reads were filtered and clipped. Raw sequences 442 
were analysed with open source software Edge Bioinformatics (v.2.0.0). 443 
 444 
Scanning electron microscopy analysis 445 
One cm tubing sections were cut in half lengthwise and incubated overnight in 2.5% 446 
glutaraldehyde solution (Contain™, Fisher Scientific, Loughborough, UK) followed by 447 
immersion in successive concentrations of ethanol for 10 minutes each (10%, 25%, 50%, 448 
70%, 90%, 100%). Prior to SEM scanning, samples were coated with 20 nm AuPd coating 449 
with sputter coater (SC500, Biorad, UK).  Secondary electron images were acquired with a 450 
beam energy of 5kV using an in-lens detector on a Sigma HD Field Emission Gun Scanning 451 
Electron Microscope (Carl Zeiss Ltd., Cambridge, UK) at 1,000x magnification and 5-7 mm 452 
working distance with the help of Earth and Ocean Sciences Department, Cardiff University, 453 
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UK. The images were false-coloured using GNU Image manipulation program (GIMP 2.8) 454 
software. The images were not otherwise altered.  455 
 456 
Statistical analysis 457 
Statistical significance of data sets was evaluated with GraphPad PRISM® (ver. 7.04) using 458 
Single-way ANOVA. The statistical analysis was performed at a 0.05 confidence level (p < 459 
0.05), comparing the effect of different disinfectant treatments on drain biofilm viability. 460 
Standard deviation of environmental and technical replicates was evaluated with Bassel’s 461 
correction. All measurements, if not stated otherwise, were performed in triplicates. Each 462 
triplicate was plated in two environmental replicates.   463 
 464 
  465 
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Results 466 
 467 
Drain biofilm viability 468 
There was no statistically significant difference (Single-way ANOVA, P = 0.8295) in viable 469 
aerobic counts between the front, middle and back tubing sections in trap model from 7 470 
independent drain biofilm batches. The average total bacterial number recovered from the 471 
front, middle and back sections were 8.3 ± 0.6, 8.5 ± 0.7 and 8.3 ± 0.7 log10 CFU/cm2, 472 
respectively. 473 
 474 
Drain biofilm development and appearance 475 
During two-days inoculation phase, drain biofilm culture adhered into silicone tubing. Under 476 
no flow conditions bacteria grow in evenly scattered firm clusters (Figure 1). The biofilm was 477 
then subjected to periodical flushes when 10% TSB was supplied at 30 mL/min for 10 478 
seconds every 2 hours. Bacteria started to establish biofilm communities, which can be 479 
observed as dense matrix with distinctive extracellular polymeric substances (EPS) (Figure 480 
1). After two days of periodically flushing the media through drain biofilm, bacteria covered 481 
larger surface area. At the end of the 8th day, the drain biofilm established a rigid thick layer 482 
of tightly embedded cells (Figure 1).  483 
 484 
Drain biofilm composition 485 
The composition of the drain biofilm at front, middle and back sections from 3 independent 486 
batches is given in Table S1. Overall, 119 different species were identified, with 76 species 487 
detected in 2 or more samples. The most prevalent species included K. oxytoca (12-33%, 488 
av. 22%), E. coli (3-47%, av. 20), K. pneumoniae (10-27%, av. 19%), S. marcescens (0.001-489 
33%, av. 10%), E. cloacae (4-10%, av. 8%), S. bongori (2-16%, av. 5%), E. pyrifoliae (0.4-490 
9%, av. 4%) and E. aerogenes (2-6%, av. 4%).   491 
  492 
Jo
urn
al 
Pr
e-p
roo
f
 11 
Product efficacy: decrease in bacterial viability in the trap model after 3 x 15 min doses 493 
In practice, drain treatments are often repeated on different dates or are applied more 494 
frequently when the product is being used for the first time to eradicate the heavy biofilm that 495 
accumulated in untreated drains for a prolonged period of time. After three consecutive 15 496 
min daily doses, NaOCl (1,000 ppm), NaDCC (1,000 ppm) and PAA (4,000 ppm) treatments 497 
were effective at killing bacteria in the drain biofilm in the front section of the trap model (5.1, 498 
4.5 and 6.0 Log10 reduction in bacterial viability, respectively). NIS <5% treatment decreased 499 
viability by 3.0 Log10 only in the front section (Figure 2). 500 
The performance of most disinfectants in treating the complex biofilm in the middle and back 501 
sections of the trap model was lower than their performance in the front sections. NaOCl 502 
(1,000 ppm), NaDCC (1,000 ppm) and NIS (<5%) products decreased biofilm viability by 2.4, 503 
1.6 and 1.4 log10 reduction at middle, 2.9, 0.7 and 0.8 log10 reductions at back sections, 504 
respectively (Figure 6). PAA (4,000 ppm) with 3x 15 min doses performed very well in the 505 
middle and back sections: 7.1 log10 reduction in the middle and 7.0 log10 reduction in back 506 
sections, respectively (Figure 2).  507 
 508 
 509 
Product efficacy: 4-days regrowth test 510 
Biofilm recovered slowly from the front section (Figure 3), while biofilm recovery was rapid in 511 
the middle and back section, notably for NaOCl (1,000 ppm) with a circa 2 log10 increase in 512 
number.  Not surprisingly bacterial number in all 3 drain sections remain high 4 days after 513 
NaDCC (1,000 ppm) or the NIS treatments (Figure 3).  Four days after treatment with PAA 514 
(4,000 ppm; 3 x 15 min doses), bacterial viability within the drain biofilm remained low (0.6 ± 515 
0.5, 0.2 ± 0.4 and 0.1 ± 0.2 log10 recovered for front, middle and back sections, respectively) 516 
and was significantly lower compared to the other treatments (Single-way ANOVA, P < 0.05 517 
for all treatments and trap sections, with the exception of NaDCC front with P = 0.1878) 518 
(Figure 8).  519 
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Discussion 520 
 521 
Drain biofilm model  522 
In our in vitro model, a mature complex biofilm was grown for an overall period of 8 days. 523 
This biofilm formation period is a compromise between allowing the development of mature 524 
biofilm and enabling the rapid testing of disinfectants. We acknowledge that it does not 525 
represent a complex drain biofilm formed over years in hospital water lines [4].  526 
 527 
Looking at biomass, initial attachment and EPS production, Andersson et al. showed that the 528 
strongest biofilm is formed by a mixture of 13 various species, as opposed to single or dual 529 
species biofilms of the same strains [8]. Bacteria thrive in a highly diverse community, and 530 
such varied complex biofilms will be found in hospital drain traps [9]. The drain biofilm 531 
formed in our model is a multi-species community, mainly composed of gram-negative 532 
bacteria that belong to Enterobacteriaceae family. Few of the species present in our drain 533 
biofilm culture were reported as linked to drain associated hospital infections, including: 534 
Klebsiella pneumoniae [10], Klebsiella oxytoca [11], Enterobacter cloacae, Enterobacter 535 
aerogenes, Enterobacter asburiae [12], Raoultella ornithinolytica [3] and Serratia 536 
marcescens [13]. Some of the species reported by McBain et al. [14] in their study on 537 
domestic drains were also isolated from our sink U-bend. It needs to be stressed out, 538 
however, that 16S rRNA gene sequencing used in this study is limited to detection of 539 
bacterial and archaeal isolates. Therefore, the role of fungus species in our drain biofilm 540 
model composition remains unknown.   541 
No distinctive difference in drain biofilm composition was observed by NGS between the 542 
front, middle and back sections of our trap model.  543 
 544 
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Drain biofilm susceptibility to disinfection 545 
Elimination of bacteria from all sections of the drain biofilm model is essential to prevent the 546 
spread of pathogens, as bacteria from drain biofilm can migrate to the entire drain [1,4,15]. 547 
Successful disinfection treatment should therefore be able to effectively control all parts of 548 
drainage system. It is important to conduct tests with drain system models that imitate those 549 
parts, just like the one developed in this study. In the study presented here we investigated 550 
the effect of the disinfectant treatments on drain biofilm viability following three 15 min 551 
consecutive doses; however, it needs to be stressed out that the amount of biomass 552 
detached by the action of disinfectant has not been investigated. Therefore, the efficacy of 553 
the disinfectants presented here might result from their ability to inactivate cells, but also 554 
from their effect on the extracellular matrix, contributing to drain biofilm detachment.  555 
Our study showed that biofilms in the trap and back sections were not controlled by NaOCl 556 
(1,000 ppm), following 3 x 15 min daily doses.  In addition, NaOCl (1,000 ppm) disinfection 557 
wore off quickly, with drain biofilm recovering within days post treatment. Poor performance 558 
of chlorine was shown in another study, where only 2 log10 reduction against drain biofilm 559 
was achieved with 6% NaOCl treatment [16].  During a drain-associated A. baumannii 560 
outbreak, disinfection with NaOCl 5 times a day was not effective and the outbreak was only 561 
controlled when sinks were replaced [17]. Sodium hypochlorite solution was also not 562 
effective in stopping a drain-related A. baumannii outbreak in France [18] or a K. 563 
pneumoniae outbreak in Spain [19].  564 
Other studies reported that bleach was effective to combat hospital drain related infections, 565 
although complex interventions were implemented. Disinfection with 0.1% sodium 566 
hypochlorite was part of an interventions undertaken to successfully tackle Acinetobacter 567 
baumannii outbreak at National Taiwan University Hospital [20]. Similar results were 568 
obtained by La Forgia et al., where weekly cleansing protocol of the whole drainage system 569 
with diluted sodium hypochlorite significantly reduced A. baumannii infection rates [21].  570 
  571 
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NaDCC has been considered safer than NaOCl when used in a tablet form [22]. Some 572 
manufacturers recommend using their NaDCC tablets for drain cleaning, and their advised 573 
concentration of available chlorine ranges from 250 to 500 ppm. Peer-reviewed information 574 
on the efficacy of NaDCC on drain biofilm eradication is scarce. Our study showed that 575 
1,000 ppm NaDCC-based product was not effective against the biofilm in all the drain 576 
sections even following 3 x 15 min daily doses. 577 
PAA (4,000 ppm) was found to be very effective on our model in all drain sections. Other 578 
studies reported the efficacy of PAA against biofilm formed on PVC piping [23] and against 579 
E. coli biofilm from a drinking water pipeline system [24]. The formation of foam following 580 
mixing the PAA product with water might have contributed to an enhanced efficacy. Foam 581 
products have been found more effective in drain decontamination as compared to their 582 
liquid equivalents [25]. 583 
As shown in our study, biofilms in drains regrow quickly and rapidly even after treatment 584 
reducing effectively biofilm viability. Similar findings were showed in the study of Jones et al., 585 
where drain biofilm regrew to its initial concentration within 7 days post treatments with 4 586 
different foaming products [25]. Buchan et al showed that following bleach or H2O2 587 
treatments, biofilm fully recovered within 7 days [16]. Quick recovery of drain biofilm is an 588 
unavoidable fact that underlines the importance of frequent disinfection.  589 
 590 
Modelling complex drain biofilm in sink trap  591 
The drain biofilm model developed in this study is a cheaper alternative to performing in vivo 592 
studies, when product is tested in full scale sink. The model allows to form and grow 6 lines 593 
of identical drain biofilms simultaneously, allowing for many testing possibilities, notably with 594 
realistic sink usage scenarios with the introduction of liquids commonly poured down the 595 
hospital sink such as IV fluid, coffee with sugar, urine, etc. The trap model generates much 596 
less pathogenic waste and is less prone to cross-contamination due to its contained 597 
structure as compared to actual sink (Table S2). It also occupies significantly less amount of 598 
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space, thanks to its compact design (an alternative of 6 identical full-scale sink might take up 599 
to whole room).  600 
However, the model does have its limitations. In usual sink design, the trap outlet pipe is 601 
located at a lower level than trap inlet pipe. Intensively foaming product would therefore 602 
escape entirely through output pipe, not reaching the strainer. Inlet tube in our trap model is 603 
levelled 3 cm above the outlet tube; however, we still observed some of the PAA product 604 
foam up to the front part. Moreover, the front section does not reflect the complex structure 605 
of a sink strainer. The material used as biofilm attachment substrate is chemically different to 606 
PVC, PP and other plastics commonly utilised as drainage pipes. As there are limited 607 
studies on effectiveness of disinfection against drain biofilms, the model would also need to 608 
be validated against full scale sink.  609 
Conclusion 610 
The in vitro drain biofilm model presented in this study allowed for reproducible testing 611 
against a complex biofilm, including measuring viability, composition, regrowth post-612 
treatment and biofilm structure in different parts of the drain. The disinfection susceptibility 613 
test shown that widely used bleach is only partially effective against drain biofilm, with good 614 
efficacy at the front section following three consecutive doses and no substantial reduction in 615 
bacterial viability at middle and back sections of the model. Moreover, biofilm is steadily 616 
recovered four days after the last sodium hypochlorite 1,000 ppm dose. On the contrary, 617 
three consecutive 15 min doses of peracetic acid 4,000 ppm were highly successful at 618 
eradicating and preventing biofilm regrowth in every part of the drain model. 619 
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Abbreviation Form 
Main active 
ingredient1 
Excipients1 
Concentration of 
the main active 
ingredient (ppm)2 
pH3 
Application in 
the drain 
biofilm model 
NaOCl 1,000 
ppm 
Liquid solution Sodium hypochlorite n/a 1,000 11.31 Through pump 
NaDCC 
1,000 ppm 
Liquid solution 
(tablet dissolved in 
water) 
Sodium 
dichloroisocyanurate 
Adipic acid, sodium toluene 
sulphonate, sodium n -
lauroylsarcosinate 
1,000 5.93 Through pump 
NIS <5% Liquid solution 
Non-ionic 
surfactants <5% 
Perfumes Not given 6.45 Through pump 
PAA 4,000 
ppm 
Granules mixed with 
water - foaming 
liquid 
Peracetic acid 
Sodium percarbonate, Citric 
acid, Sodium Lauryl Sulfate 
4,0004 8.12 
Directly into 
the ø9mm tube 
1
 Main active ingredient and excipients mentioned in the MSDS information of the commercial products used in this study. 
2
 Concentration of available chlorine/peracetic acid concentration was measured with Pocket Colorimeter™ (HACH®, Manchester, 
UK) (regardless of the product claim on label) via DPD method. 
3
 pH was measured by FiveEasy Standard pH Meter (Mettler-Toledo Ltd., Leicester, UK) 
4 Initial concentration on application 
 
Table I. Characteristics of the products tested 
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 Figure 1. Drain biofilm development over time. Images are representative observations from 3 independent drain biofilm batches. 
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Figure 2. Total viable recovered (Log10) from different sections of the model following product 
treatment 3 x 15 min dose. ■ ■ ■ Front sec!on,  Middle sec!on,  Back sec!on 
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Figure 3. Log10 CFU/cm
2
 of bacteria recovered from biofilm 4 day after a series of 3 x 15 min 
treatments. ■ ■ ■ Front sec on,  Middle sec on,  Back sec on 
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